What is the price target for MET stock?
22 analysts have analysed MET and the average price target is 93.45 USD. This implies a price increase of 22.89% is expected in the next year compared to the current price of 76.04.
METLIFE INC (MET) Forecast, Price Target & Analyst Ratings
NYSE:MET • US59156R1086
Current stock price
76.04 USD
+0.68 (+0.9%)
At close:
77 USD
+0.96 (+1.26%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for METLIFE INC (MET).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $2.21
- Revenue Estimate
- 19.518B
Price Target Details & History
Consensus Price Target and Range
Mean target
$93.45
Upside
+ 22.89%
From current price of $76.04 to mean target of $93.45, Based on 22 analyst forecasts
Low
$80.80
Median
$93.84
High
$108.15
Price Target Revisions
1 Month
-1.57%
3 Months
-3.02%
Price Target Summary
22 Wall Street analysts provided a forecast for the next 12 months for MET. The average price target is 93.45 USD. This implies a price increase of 22.89% is expected in the next year compared to the current price of 76.04.
The average price target has been revised downward by 3.02% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
79.09%
MET was analyzed by 22 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about MET.
In the previous month the buy percentage consensus was at a similar level.
MET was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | B of A Securities | Maintains | Buy -> Buy |
| 2026-04-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-04-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-04-09 | UBS | Maintains | Buy -> Buy |
| 2026-04-09 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-04-08 | Barclays | Maintains | Overweight -> Overweight |
| 2026-03-26 | Keefe, Bruyette & Woods | Reiterate | Outperform -> Outperform |
| 2026-03-11 | TD Cowen | Maintains | Buy -> Buy |
| 2026-03-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-11 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-05 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-08 | UBS | Maintains | Buy -> Buy |
| 2025-12-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-16 | Mizuho | Initiate | Outperform |
| 2025-11-11 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-19 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-09-16 | Wolfe Research | Initiate | Outperform |
| 2025-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $2.21
- Revenue Estimate
- 19.518B
- Revenue Q2Q
- 3.67%
- EPS Q2Q
- 12.97%
- Number of Analysts
- 16
Next Earnings Revisions
Revenue (1 Month)
-0.72%
Revenue (3 Months)
-0.34%
EPS (1 Month)
-0.40%
EPS (3 Months)
-1.95%
Next Earnings Summary
MET is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 2.21 USD and the consensus revenue estimate is 19.52B USD.
The next earnings revenue estimate has been revised downward by 0.34% in the past 3 months.
Full Analyst Estimates 2026 - 2029
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 66.851B -4.36% | 71.048B 6.28% | 76.994B 8.37% | 80.884B 5.05% | 84.562B 4.55% | 88.298B 4.42% | 93.185B 5.53% | |
| EBITDA YoY % growth | 3.871B -13.40% | 7.435B 92.07% | 6.385B -14.12% | 8.683B 35.99% | N/A | N/A | N/A | |
| EBIT YoY % growth | 3.153B -16.96% | 6.721B 113.16% | 5.632B -16.20% | 9.23B 63.88% | 9.856B 6.78% | 10.43B 5.82% | N/A | |
| Operating Margin | 4.72% | 9.46% | 7.31% | 11.41% | 11.66% | 11.81% | N/A | |
| EPS YoY % growth | 7.34 7.31% | 8.14 10.90% | 8.93 9.71% | 9.90 10.83% | 11.05 11.68% | 12.35 11.74% | 12.98 5.09% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.21 12.97% | 2.51 24.34% | 2.56 7.97% | 2.60 0.77% | 2.49 12.39% | 2.80 11.51% | 2.84 11.06% | 2.89 11.02% | 2.64 6.27% | 3.03 8.02% | 3.17 11.69% | 3.12 8.09% |
| Revenue Q2Q % growth | 19.518B 3.67% | 20.087B 12.09% | 20.258B 13.17% | 20.866B -13.74% | 20.555B 5.31% | 21.158B 5.33% | 21.266B 4.98% | 21.915B 5.03% | 21.715B 5.64% | 21.937B 3.68% | 22.114B 3.99% | 23.151B 5.64% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 2.013B 25.97% | 2.124B 70.06% | 2.213B 48.03% | 2.184B 76.27% | 2.169B 7.75% | 2.278B 7.25% | 2.371B 7.14% | 2.334B 6.87% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
11.41%
EPS Next 5 Year
9.80%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
2.11%
Revenue Next 5 Year
2.95%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
METLIFE INC / MET Forecast FAQ
Can you provide the upcoming earnings date for METLIFE INC?
METLIFE INC (MET) will report earnings on 2026-05-06, after the market close.
What are the consensus estimates for METLIFE INC (MET) next earnings?
The consensus EPS estimate for the next earnings of METLIFE INC (MET) is 2.21 USD and the consensus revenue estimate is 19.52B USD.
Can you provide the expected long term growth rate for METLIFE INC stock?
The expected long term growth rate for METLIFE INC (MET) is 2.11%.